Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954.
AuthorsDjeha, A Hakim
Hulme, Alison N
Dexter, T Michael
Young, Lawrence S
Searle, Peter F
Kerr, David J
Wrighton, Christopher J
AffiliationCobra Therapeutics Ltd., The Science Park, University of Keele, United Kingdom. email@example.com
MetadataShow full item record
AbstractExpression of the Escherichia coli enzyme nitroreductase (NTR) in mammalian cells enables them to activate the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954), leading to interstrand DNA cross-linking and apoptosis in both proliferating and quiescent cells. In the work reported here, we used human hepatocellular carcinoma and squamous carcinoma cell lines constitutively expressing NTR to demonstrate that the ntr/CB1954 system results in potent, long-lasting antitumoral effects in mice. We also demonstrate that this enzyme/prodrug combination results in antitumoral effects in vivo when only a minority of tumor cells express the enzyme, using either cells constitutively expressing NTR or ntr gene delivery in situ.
CitationExpression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954. 2000, 7 (5):721-31 Cancer Gene Ther.
JournalCancer Gene Therapy
- Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
- Authors: Djeha AH, Thomson TA, Leung H, Searle PF, Young LS, Kerr DJ, Harris PA, Mountain A, Wrighton CJ
- Issue date: 2001 Feb
- Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.
- Authors: McNeish IA, Green NK, Gilligan MG, Ford MJ, Mautner V, Young LS, Kerr DJ, Searle PF
- Issue date: 1998 Aug
- Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene.
- Authors: Green NK, Youngs DJ, Neoptolemos JP, Friedlos F, Knox RJ, Springer CJ, Anlezark GM, Michael NP, Melton RG, Ford MJ, Young LS, Kerr DJ, Searle PF
- Issue date: 1997 Jul-Aug
- Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.
- Authors: White CL, Menghistu T, Twigger KR, Searle PF, Bhide SA, Vile RG, Melcher AA, Pandha HS, Harrington KJ
- Issue date: 2008 Mar
- The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954.
- Authors: Drabek D, Guy J, Craig R, Grosveld F
- Issue date: 1997 Feb